SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales figure stood at Rs. 410.80 millions for the March 2022 quarter. The mentioned figure indicates a growth of about 29.10% as compared to Rs. 318.20 millions during the year-ago period.The Net Loss for the quarter ended March 2022 is Rs. -11.66 millions as compared to Net Profit of Rs. 38.18 millions of corresponding quarter ended March 2021Operating profit Margin for the quarter ended March 2022 slipped to -8.18% as compared to 55.62% of corresponding quarter ended March 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 410.80 318.20 29.10 2555.49 2133.31 19.79 2555.49 2133.31 19.79
Other Income 17.14 12.79 34.01 77.20 28.17 174.05 77.20 28.17 174.05
PBIDT -8.18 55.62 -114.71 634.93 644.99 -1.56 634.93 644.99 -1.56
Interest 2.78 3.80 -26.84 7.31 15.97 -54.23 7.31 15.97 -54.23
PBDT -10.96 51.82 -121.15 627.62 629.02 -0.22 627.62 629.02 -0.22
Depreciation 5.71 0.56 919.64 14.32 4.09 250.12 14.32 4.09 250.12
PBT -16.67 51.26 -132.52 613.30 624.93 -1.86 613.30 624.93 -1.86
TAX -5.01 13.08 -138.30 160.21 159.59 0.39 160.21 159.59 0.39
Deferred Tax 3.23 -0.43 -851.16 4.51 -5.10 -188.43 4.51 -5.10 -188.43
PAT -11.66 38.18 -130.54 453.09 465.34 -2.63 453.09 465.34 -2.63
Equity 100.00 100.00 0.00 100.00 100.00 0.00 100.00 100.00 0.00
PBIDTM(%) -1.99 17.48 -111.39 24.85 30.23 -17.82 24.85 30.23 -17.82

Nureca Ltd. Share Price

258.70 -5.10 (-1.93%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Lenskart Solutions 533.70
Poly Medicure 1455.50
Laxmi Denta 193.25
Nureca Ltd. 258.70
Hemant Surgical Inds 308.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×